Other languages bluebird bio, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
0.9228 ^USD	+1.13%		-9.53%	-33.13%

04-26	Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report	MT
03-27	Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating	MT

Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report	04-26
Bluebird bio to Restate Financial Statements; Shares Fall	03-26
Gene therapy maker bluebird to restate 2022 financials after accounting error	03-26
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	03-18
Sector Update: Health Care	03-18
Bluebird bio Secures $175 Million Term Loan Facility	03-18
Bluebird bio Signs Medicaid Agreement for Sickle Cell Disease Therapy with Michigan State	03-11
Bluebird bio, Inc. Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy	03-11
Top Midday Decliners	12-20
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	12-20
Top Premarket Decliners	12-20
Bluebird bio Prices $125 Million Stock Offering at $1.50 a Share	12-20
MORNING BRIEFING - Deutschland/Europa	12-20
MÄRKTE USA/Wall Street erklimmt neue Rekordmarken	12-19
MÄRKTE USA/Wall Street mit neuen Rekordmarken	12-19
MÄRKTE USA/Leichte Aufschläge zum Start - Rekordjagd hält an	12-19
MÄRKTE USA/Leichte Aufschläge erwartet	12-19
Bluebird bio Launches $150 Million Share Offering; Shares Slump Premarket	12-19
MARKT USA/Leichte Aufschläge erwartet	12-19
Bluebird bio Launches $150 Million Share Offering	12-19

No results for this search